# Alethio Therapeutics funding rounds and investors

As of 5 Nov 2026, Alethio Therapeutics has raised $90M across 1 verified round on record; latest: $90M (£67M) Series A led by RA Capital Management and Sofinnova Partners, announced 5 Nov 2026.

A biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs)

Website: https://alethiotherapeutics.com  
Headquarters: Oxford, UK  
Page: https://fireround.dev/companies/alethio-therapeutics

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-05 | Series A | $90M (£67M) | RA Capital Management, Sofinnova Partners | Cancer Research Horizons, Oxford Science Enterprises, University of Oxford | [globenewswire.com](https://www.globenewswire.com/news-release/2026/11/05/3396088/0/en/alethio-therapeutics-raises-90-million-67-million-in-oversubscribed-series-a-financing-to-advance-a-new-generation-of-therapies-for-myeloproliferative-neoplasms.html), [finsmes.com](https://www.finsmes.com/2026/11/alethio-therapeutics-raises-90m-in-series-a-funding.html), [manilatimes.net](https://www.manilatimes.net/2026/11/05/tmt-newswire/globenewswire/alethio-therapeutics-raises-90-million-67-million-in-oversubscribed-series-a-financing-to-advance-a-new-generation-of-therapies-for-myeloproliferative-neoplasms/2462554) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.